Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04257448
Title Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer (SEPION)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GWT-TUD GmbH
Indications

pancreatic ductal adenocarcinoma

Therapies

Gemcitabine + Nab-paclitaxel + Romidepsin

Azacitidine + Gemcitabine + Nab-paclitaxel

Azacitidine + Gemcitabine + Nab-paclitaxel + Romidepsin

Gemcitabine + Nab-paclitaxel

Durvalumab + Lenalidomide

Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Essen Recruiting Essen 45147 Germany Details
Universitätsklinikum Frankfurt Recruiting Frankfurt 60590 Germany Details
Universitätsmedizin Göttingen Recruiting Göttingen 37075 Germany Details
Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg 20251 Germany Details
Uniklinik Köln Recruiting Köln 50937 Germany Details
Ludwig-Maximilians-Universität München Recruiting München 81377 Germany Details
Klinikum Nürnberg Recruiting Nürnberg 90419 Germany Details
Universitätsklinikum Ulm Recruiting Ulm 89081 Germany Details
Universitätsklinikum Würzburg Recruiting Würzburg 97080 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field